about
Pediatric Statin Administration: Navigating a Frontier with Limited DataFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesOptical Isomers of Atorvastatin, Rosuvastatin and Fluvastatin Enantiospecifically Activate Pregnane X Receptor PXR and Induce CYP2A6, CYP2B6 and CYP3A4 in Human HepatocytesA Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.Drug interactions with angiotensin receptor blockers.A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in womenFasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatmentHerbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.Statins and renal function.Cytochrome P450 2C8 pharmacogenetics: a review of clinical studiesSex-dependent modulation of treatment responseAntihypertensive therapy: special focus on drug interactions.The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.Fluvastatin and fluvastatin extended release: a clinical and safety profile.In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.The human intestinal cytochrome P450 "pie".Lipid-lowering effects of statins: a comparative review.Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population.Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1.Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan.Pharmacokinetic and pharmacodynamic alterations in older people with dementia.Quantitative Analyses of Hepatic OATP-Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method.Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins.Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin.The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin.No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers.Stereospecific disposition of fluvastatin in streptozotocin-induced diabetic rats.Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.Combined organ failure with combination antihyperlipidemic treatment: a case of hepatic injury and acute renal failure.Modeling the effects of commonly used drugs on human metabolism
P2860
Q28068014-E24C6657-5BC8-4731-B13F-94AEB24F4181Q28182631-D545F45B-7C31-4324-A514-CAD432F86690Q28547949-4AFF4E09-54A4-4082-AB8C-3F3D86CDD250Q30400569-3B782943-6428-4CBA-85A0-798DC1AD7A49Q33211891-0BC53EE7-A186-4A07-98BA-62E1A7130196Q33634188-1A842C43-CC65-48DB-B78B-8E9E72DA340AQ33697158-EFE75D64-5823-4BD2-B510-795520DD2101Q33867239-A44198F0-5D00-481E-A8EA-2AE750B336E5Q34940824-373E8B7F-A5D3-4CBD-8FEA-8B17B729CE35Q35003605-F6906515-3BAF-40D7-B0AF-39683AD07974Q35236761-B0DB19DF-5C44-4286-8CAB-B8514D019195Q35570981-B72B013F-9364-413E-9713-D37AF3C731CFQ35827277-D4F596C1-EF16-483D-B15A-61DE96CE50A0Q35879055-02B71E10-B2DB-4D82-B75C-C2BBC563787CQ36094897-D5826FAE-B2CD-4955-B17C-7D9F0B6B6C97Q36420382-0E6E649C-D089-4F57-A880-6F8DD07357DDQ36573878-E225FF22-25B6-4CB3-BA47-1F3966E480DDQ36577254-791977D9-80F1-445C-BFE1-69CBBBE627A6Q37601039-441B9747-80B2-482F-8B73-55EDABF3FAA3Q37765899-E7165414-2174-48B2-91D7-CCBEC70D1811Q38049379-51D9CC5C-3BA4-459C-BF9D-78DD6940C88FQ38050686-FF109437-6E1C-45F0-842D-CA5C2659740EQ38078561-60198380-7A3E-486C-9419-EAFFB2469589Q38109095-7C14A3FD-FA75-487D-8857-71D092DEC00EQ38155218-FD18662B-F548-4A87-A92C-5D5BF025D330Q38608556-1E6CB018-B958-4216-8151-F278CD4494E9Q39275819-75E0B7E9-C884-41EE-91A3-2BB8ACD9630FQ39773424-8A9DB0D3-F48E-4124-AD51-FCB8CA891C86Q40391830-39CECC5F-A606-4487-BC40-7019D8735479Q40916355-061FC6E6-E9F6-4BF4-BD22-2991A0BADD57Q41896286-4FC68E83-2541-41EC-85B1-0F4830A1C630Q42084968-C55A892A-6166-406F-9CC6-C595046F7CD6Q44051714-19D194A3-CC53-4B8A-B782-869BB5DA98E7Q44237130-CA9BBBD4-8421-4A1A-BAE9-AB7706E3687FQ44254467-3E0B88AD-9F51-467B-AB77-3B856D1C8B99Q44530977-1C48DC40-84CB-4A33-8AAA-9D646217B331Q47330563-CE243048-BBC6-4B10-8513-4DF85531D73BQ50712735-43DF4BD6-4157-4197-B728-BE68FF5C2060Q57004702-47D91CC5-2F54-44C6-A6CC-985666EE50C0
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical pharmacokinetics of fluvastatin.
@ast
Clinical pharmacokinetics of fluvastatin.
@en
Clinical pharmacokinetics of fluvastatin.
@nl
type
label
Clinical pharmacokinetics of fluvastatin.
@ast
Clinical pharmacokinetics of fluvastatin.
@en
Clinical pharmacokinetics of fluvastatin.
@nl
prefLabel
Clinical pharmacokinetics of fluvastatin.
@ast
Clinical pharmacokinetics of fluvastatin.
@en
Clinical pharmacokinetics of fluvastatin.
@nl
P1476
Clinical pharmacokinetics of fluvastatin.
@en
P2093
C D Scripture
J A Pieper
P304
P356
10.2165/00003088-200140040-00003
P577
2001-01-01T00:00:00Z
P6179
1028144826